Free tool
Healthcare stocks
We cover 27 companies in the Healthcare sector. The median market value in the group is $3.74B. Across the group, the median move over the past trading day is −0.91%. 54% of the 26 with a 200-day average trade above it. Price change over the past year runs from −27.4% to +54.2% across the middle 80 percent of the group, with a median of +4.0%.
Other lists in this group
Table
27 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% | Nov 2, 2026 |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% | Nov 10, 2026 |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% | Aug 27, 2026 |
| 2413.T | M3, Inc. | $7.53B | Mid cap | −17.22% | Nov 11, 2026 |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% | Oct 29, 2026 |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% | Nov 4, 2026 |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +5.97% | Oct 9, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +15.35% | Oct 23, 2026 |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% | Nov 13, 2026 |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% | Nov 12, 2026 |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.89B | Mid cap | −11.24% | Nov 5, 2026 |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% | Oct 29, 2026 |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.05B | Mid cap | −3.59% | Oct 30, 2026 |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% | Nov 5, 2026 |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% | Nov 5, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% | Oct 13, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% | Oct 8, 2026 |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.34% | Nov 13, 2026 |
| 2784.T | Alfresa Holdings Corporation | $2.53B | Mid cap | +6.80% | Nov 9, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% | Oct 1, 2026 |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% | Aug 27, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −20.29% | Oct 26, 2026 |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −12.93% | Nov 12, 2026 |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% | Oct 29, 2026 |
| 4563.T | AnGes, Inc. | $97.61M | Micro cap | −60.42% | Nov 6, 2026 |
| 4875.T | MediciNova, Inc. | $71.04M | Micro cap | +11.17% | Nov 12, 2026 |
| 4582.T | SymBio Pharmaceuticals Limited | $31.19M | Micro cap | −57.43% | Oct 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.